AOTI, Inc. (GB:AOTI) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
AOTI, Inc. reports a robust 26.5% revenue growth for the first half of 2024, reaching $26.3 million, driven by strong second-quarter performance that balanced out a slower start to the year. The medical technology company, specializing in wound healing and amputation prevention, has also expanded its market reach with FDA clearance for home care use of its NEXA NPWT System and secured a significant contract with a major Workers Compensation services company. AOTI remains confident in achieving over 30% revenue growth for the full year, with full interim results to be disclosed in September.
For further insights into GB:AOTI stock, check out TipRanks’ Stock Analysis page.
